VSee Health, Inc. (VSEE)

VSEE's stock price has decreased significantly over the last year, but Q3 2025 saw revenue growth. The company regained Nasdaq compliance and announced a stock offering. VSee Health secured a major contract and achieved FedRAMP authorization. The company also launched its AI-enhanced Rural Health Transformation Solution.

While specific demand seasonality is not explicitly detailed, the telehealth market experienced a surge during the COVID-19 pandemic, followed by a decline. The telehealth market is projected for significant growth, driven by increasing demand for accessible healthcare, advancements in telecommunication technologies, and the rising prevalence of chronic diseases. VSee Health's focus on integrated telehealth and professional services positions it within a growing segment of the healthcare industry.

VSee Health operates as a telehealth software platform, providing a no-code or low-code SaaS solution for healthcare providers to develop and integrate telehealth workflows. The company offers a comprehensive telehealth platform designed for secure text and video collaboration, HIPAA compliance, and customizable virtual waiting rooms and clinics. Major products and services include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote Patient Monitoring, VSee Telehealth Staffing, iDoc Telehealth Solutions, and AI-driven solutions.

VSee Health has a global reach, with services deployed in over 50 countries, serving clients such as NASA, HHS, McKesson, DaVita, and the nation of Qatar. The company also powers hospital systems, health networks, and employers across the United States and is expanding in Southeast Asia, including the Philippines.

VSee Health maintains a strong brand reputation, particularly within the telehealth and government sectors. Achieving FedRAMP High ATO, launching the AI-Enhanced Rural Health Platform, conducting successful medical missions, securing strategic partnerships and contracts, and innovating in AI documentation have positively impacted VSee Health's reputation. The company has been navigating short-seller activity since its Nasdaq listing.

VSee Health has a mix of institutional and individual insider ownership. Institutional investors hold between 1.01% and 3.36% of the stock, while insiders collectively own between 16.1% and 25.58%. Imoigele Aisiku is the largest individual shareholder.